David V. Morrissey
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di David V. Morrissey
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Biotechnology | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a David V. Morrissey tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Public Communications Contact | |
| ABBVIE INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer Public Communications Contact | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Public Communications Contact | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member Director/Board Member Public Communications Contact | |
| AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Chief Operating Officer | |
| Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
| F-STAR THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Investor Relations Contact | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| College des Ingenieurs | College/University | Masters Business Admin | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
| Université Libre de Bruxelles | College/University | Doctorate Degree | |
| University of Mons Hainaut | College/University | Corporate Officer/Principal | |
Agency for Science, Technology & Research
 Agency for Science, Technology & Research Miscellaneous Commercial ServicesCommercial Services Agency for Science, Technology & Research engages in fostering scientific research and development. It is the agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. The company was founded in 1991 and is headquartered in Singapore. | Miscellaneous Commercial Services | Director/Board Member | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Longwood Fund Management LLC
 Longwood Fund Management LLC Investment ManagersFinance Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Consultant / Advisor | |
| Université de Mons | College/University | Corporate Officer/Principal | |
| Tufts University | College/University | Graduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member | |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services The PhRMA Foundation is an organization that provides awards and support to individuals pursuing higher education. The non-profit company is based in Washington. The organization's 2022 annual report highlights their activities and showcases their 2022 awardees. | Miscellaneous Commercial Services | Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Chairman | |
ModernaTX, Inc.
 ModernaTX, Inc. BiotechnologyHealth Technology Modernatx, Inc. develops messenger RNA therapeutics. Its vivo drug technology that produces human proteins, antibodies and entirely novel protein constructs inside patient cells, which are in turn secreted or active intracellularly. The company was founded by Derrick J. Rossi, Doug G. Cole, Doug G. Cole, Robert S. Langer, Jr., Noubar Afeyan, and Kenneth R. Chien in 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| MODERNA, INC. | Biotechnology | Director/Board Member | |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Kynan Pharmaceuticals | Director/Board Member | ||
Galvani Bioelectronics Ltd.
 Galvani Bioelectronics Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, Galvani Bioelectronics Ltd. is a pioneering research and British development company founded in 2016, dedicated to bringing bioelectronic therapies to patients. The company is based in Stevenage, UK. Galvani Bioelectronics combines GSK's therapeutics discovery and development knowledge with Verily's expertise in software and electronics for clinical applications. The company is developing therapies through implant-based direct modulation of specific neural signals to organs central in disease. These therapies are designed to be safe, precise in their therapeutic effect, and minimally invasive in their delivery through the use of small and efficient wireless electronics and keyhole surgery. Connected software will ensure that patients and physicians can effectively control and optimize the therapy. | Pharmaceuticals: Major | Chairman | |
| Harvard Medical School | College/University | Graduate Degree | |
| LONZA GROUP AG | Pharmaceuticals: Major | Director/Board Member | |
Artizan Biosciences, Inc.
 Artizan Biosciences, Inc. Medical/Nursing ServicesHealth Services Artizan Biosciences, Inc. engages in the provision of healthcare services. It develops curative treatments for inflammatory diseases. The company was founded by Richard A. Flavell, Noah W. Palm and Marcel R. de Zoete and is headquartered in New Haven, CT. | Medical/Nursing Services | Director/Board Member | |
Monopteros Therapeutics, Inc.
 Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Director/Board Member | |
| International Institute for Management Development | College/University | Masters Business Admin | |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arrow Therapeutics Ltd. operates as a pharmaceutical company that focuses on research and development of novel antiviral drugs. Its products include novel antibacterial, antiviral, antifungal and preclinical compounds. The company was founded in 1998 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Imperial College London | College/University | Doctorate Degree | |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Cellzome Ltd. engages in the research, development, and manufacture of pharmaceutical products. It provides kinase-targeted drugs to treat inflammatory diseases. The company was founded by Gitte Neubauer on December 22, 2003 and is headquartered in Middlesex, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Director/Board Member | |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Jp Morgan Direct Corporate Finance | Corporate Officer/Principal | ||
Trickle Up Program, Inc.
 Trickle Up Program, Inc. Miscellaneous Commercial ServicesCommercial Services Trickle Up Program, Inc. is an organization that aims to end extreme poverty by partnering with women. The non-profit company is based in New York, NY. The company believes that women are agents of change and key to breaking the intergenerational cycle of poverty. The organization invests in women and provides them with training and mentoring to build sustainable livelihoods and transform their futures. Trickle Up has reached many lives since 1979 and supports savings groups. The company works through partners and provide coaching in displaced contexts. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| G.H. Besselaar Associates | Chief Tech/Sci/R&D Officer | ||
AvenCell Therapeutics, Inc.
 AvenCell Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AvenCell Therapeutics, Inc. is a biopharmaceutical company that develops immunotherapies to treat cancers. The private company is based in Cambridge, MA and has subsidiaries in Germany. Andrew D. Schiermeier has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 33 |
| Regno Unito | 9 |
| Belgio | 4 |
| Svizzera | 3 |
| Francia | 2 |
Settori
| Health Technology | 25 |
| Consumer Services | 12 |
| Commercial Services | 7 |
| Finance | 4 |
| Health Services | 3 |
Posizioni
| Director/Board Member | 169 |
| Independent Dir/Board Member | 62 |
| Corporate Officer/Principal | 35 |
| Chairman | 23 |
| Chief Executive Officer | 18 |
Contatti più connessi
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Perry Karsen | 38 |
| Nessan Bermingham | 36 |
| Caroline Dorsa | 27 |
| Moncef Slaoui | 24 |
| Sapna R. Srivastava | 22 |
| John Leonard | 17 |
| Frank Verwiel | 16 |
| Graeme Bell | 9 |
| Andrew Schiermeier | 9 |
| Thomas Barnes | 8 |
| Jennifer Mound Smoter | 8 |
| Rachel Haurwitz | 7 |
| Jennifer King | 7 |
| Jose Rivera | 5 |
- Borsa valori
- Insiders
- David V. Morrissey
- Connessioni Società
